论文部分内容阅读
目的探析对消化性溃疡并发消化道出血患者的临床治疗手段及干预效果。方法纳入分析对象为2015年至2017年在本院接受治疗的消化性溃疡并出血82例的相关临床数据,编序后采用随机数字表法将其分为A组(常规治疗联合奥美拉唑)、B组(常规治疗联合泮托拉唑)。疗程后分析疗效差异以了解泮托拉唑对消化性溃疡并出血的治疗价值。结果 B组患者临床治疗效果显著优于A组(P<0.05);疗程后对患者进行随访,期间均无患者出现药物相关不良反应(P>0.05),发生率对比提示无统计学意义。结论并发出血症状的消化道溃疡患者用泮托拉唑药物治疗能迅速控制病情恶化,短时间内促进血小板聚集并抑制胃酸分泌,对临床治疗有突出的保障效果。
Objective To explore the clinical treatment of peptic ulcer patients with gastrointestinal bleeding and intervention effect. Methods The clinical data of 82 patients with peptic ulcer and hemorrhage treated in our hospital from 2015 to 2017 were included in the analysis. After sorting, they were divided into group A (routine treatment combined with omeprazole ), Group B (conventional treatment combined with pantoprazole). After the course of treatment analysis of differences in efficacy to understand the pantoprazole peptic ulcer bleeding and the value of treatment. Results The clinical efficacy of group B was significantly better than that of group A (P <0.05). No drug-related adverse reactions occurred in patients after follow-up after treatment (P> 0.05). The incidence rate showed no significant difference. Conclusions Patients with peptic ulcer complicated by blood symptoms can quickly control the exacerbation of the disease by using the drug of pantoprazole, promote the platelet aggregation and inhibit the gastric acid secretion in a short period of time, and have outstanding protection effect on clinical treatment.